SCHEMBL14907666

SCHEMBL14907666

CC(C)(C)OC(=O)NCc1ccccc1CNC(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 2/20 0.54
FAAH O00519 2/20 0.49
TRPV1 Q8NER1 1/20 0.49
ALDH1A1 P00352 5/20 0.49
BCL9 O00512 1/20 0.44
CTNNB1 P35222 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GAA P10253 1/20 0.43
KCNA5 P22460 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
ITGA4 P13612 1/20 0.42
ITGB7 P26010 1/20 0.42
MAPK1 P28482 1/20 0.41
KDM4A O75164 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31548856 0.89 HTR2A (0.47) MGLLFAAHTRPV1ALDH1A1BCL9
SCHEMBL14907652 0.86 MGLL (0.67) MGLLFAAHTRPV1BCL9CTNNB1
SCHEMBL14907653 0.84 MGLL (0.72) MGLLFAAHTRPV1ALDH1A1BCL9
SCHEMBL1389312 0.83 MGLL (0.75) MGLLFAAHTRPV1BCL9CTNNB1
SCHEMBL18359784 0.83 MGLL (0.75) MGLLFAAHTRPV1BCL9CTNNB1
SCHEMBL27356591 0.82 MGLL (0.62) MGLLFAAHTRPV1BCL9CTNNB1
SCHEMBL12651647 0.82 MGLL (0.62) MGLLFAAHTRPV1ALDH1A1BCL9
SCHEMBL31715604 0.81 MEN1 (0.64) MGLLFAAHTRPV1ALDH1A1BCL9
SCHEMBL29587274 0.81 KMT2A (0.59) MGLLFAAHTRPV1ALDH1A1CYP2C9
SCHEMBL7068808 0.81 BCL9 (0.56) MGLLALDH1A1BCL9CTNNB1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-9174984-B2 Chemical compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2015-11-03 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
US-20140296204-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2014-10-02 US disclosed
WO-2013062945-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2013-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296204-A1 CHEMICAL COMPOUNDS DNMT1, DNMT3A, DNMT3B MGLL 2826/4885FAAH 4806/4885TRPV1 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.